Immortal by 2039? The 'examples', ‘theories’, and 'therapies' Bryan Johnson is banking on
Venture capitalist Bryan Johnson aims for human immortality by 2039, investing heavily in biotech and AI. He draws inspiration from nature's regenerative abilities and is testing experimental therapies like organoids and biomarker-driven interventions. While claiming personal progress, Johnson acknowledges scientific limitations and ongoing challenges in his ambitious quest.
Venture capitalist Bryan Johnson aims for human immortality by 2039, investing heavily in biotech and AI. He draws inspiration from nature's regenerative abilities and is testing experimental therapies like organoids and biomarker-driven interventions. While claiming personal progress, Johnson acknowledges scientific limitations and ongoing challenges in his ambitious quest.
